Whole Genome Sequencing (WGS) on IVF Embryos and Individual Patients

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

August 31, 2024

Conditions
Fertility IssuesSingle-Gene Defects
Interventions
OTHER

Embryo genome sequencing

This project proposes the testing of a cohort of research embryos to establish the key parameters for amplified trophectoderm biopsied embryos using minimum depth required for genome sequencing (\>depth of 30x per base).The remaining embryo tissue will be whole genome sequenced to validate the results of the biopsy.

OTHER

Parents genome sequencing

Analysis will be performed using trio testing of each embryo in addition to the DNA from the genetic parent to facilitate the derivation of de novo mutation rate.

Trial Locations (4)

10024

NOT_YET_RECRUITING

Neway Fertility, New York

34385

RECRUITING

Preimplantation Genetic Testing Unit ART and Reproductive Genetics Unit, Memorial Sisli Hospital, Istanbul

97205

NOT_YET_RECRUITING

ORM Fertility, Portland

98034

NOT_YET_RECRUITING

Poma Fertility, Kirkland

Sponsors
All Listed Sponsors
lead

GenEmbryomics Pty. Ltd

INDUSTRY